These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

956 related items for PubMed ID: 8563870

  • 1. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H, Munakata A, Yoshida Y.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [Abstract] [Full Text] [Related]

  • 2. Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis.
    Munakata A, Yoshida Y, Muto T, Tsuchiya S, Fukushima T, Hiwatashi N, Kobayashi K, Kitano A, Shimoyama T, Inoue M.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():108-11. PubMed ID: 8563868
    [Abstract] [Full Text] [Related]

  • 3. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM, Greenberg GR.
    Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K, Fischer C, Klotz U, Heinkel K.
    Dtsch Med Wochenschr; 1982 Jul 23; 107(29-30):1131-4. PubMed ID: 6123426
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacological bases of therapy with 5-ASA].
    Beltrán B, Martínez-Cuesta MA, Calatayud S, Hinojosa J, Esplugues JV.
    Gastroenterol Hepatol; 1997 Jul 23; 20(6):322-34. PubMed ID: 9296850
    [No Abstract] [Full Text] [Related]

  • 9. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW, Gales BJ.
    Clin Pharm; 1992 Jun 23; 11(6):514-28. PubMed ID: 1600685
    [Abstract] [Full Text] [Related]

  • 10. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Sandborn WJ.
    Rev Gastroenterol Disord; 2006 Jun 23; 6(2):97-105. PubMed ID: 16699478
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.
    Ewe K, Becker K, Ueberschaer B.
    Z Gastroenterol; 1996 Apr 23; 34(4):225-9. PubMed ID: 8686349
    [Abstract] [Full Text] [Related]

  • 13. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC, Hanauer SB.
    Rev Gastroenterol Disord; 2004 Apr 23; 4(3):104-17. PubMed ID: 15359211
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inducing and maintaining remission in ulcerative colitis: role of high-dose, extended-release mesalamine.
    Kao J, Kwok K, Das KM.
    J Clin Gastroenterol; 2010 Sep 23; 44(8):531-5. PubMed ID: 20495466
    [Abstract] [Full Text] [Related]

  • 17. [Rescue therapy with sulfasalazine prior to immunosuppressive or biological agents in ulcerative colitis poorly controlled with mesalazine].
    Martínez González J, Busto Bea V, Mesonero Gismero F, Parejo Carbonell S, Garrido E, López San Román A.
    Gastroenterol Hepatol; 2013 Jan 23; 36(1):7-10. PubMed ID: 23195755
    [Abstract] [Full Text] [Related]

  • 18. 5-ASA enema therapy.
    Hanauer SB.
    Neth J Med; 1989 Jun 23; 35 Suppl 1():S11-20. PubMed ID: 2702307
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
    Kreisel W, Wolf LM, Grotz W, Grieshaber M.
    Eur J Gastroenterol Hepatol; 1996 May 23; 8(5):461-8. PubMed ID: 8804875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.